Morningstar

Haleon PLC ADR HLN

Morningstar Rating
Unlock
Stock XNYS Rating as of
$9.13 +0.10 (1.11%)
View Full Chart
As of Delayed Price Closed

Company Report

View Archive

US Weakness Looks To Dampen 2026 Sales but Cost Savings and Efficiency Gains Lift Margins

Keonhee Kim

Haleon is one of the largest consumer healthcare companies in the world. Over the last few years, Haleon has achieved a more rationalized operation by divesting multiple non-strategic brands, slimming down its manufacturing footprint, and dialing back the number of warehouses and distribution centers. We appreciate the firm's efforts to optimize its business and believe it is well established to enjoy long-term industry trends, including an aging population, premiumization of consumer healthcare products, and growing emerging markets, that should fuel its top line.

Read Full Report

Price vs Fair Value

View History
HLN is trading within a range we consider fairly valued.
Price
$9.13
Fair Value
$13.00
Uncertainty
Stltqj
1-Star Price
$15.50
5-Star Price
$1.00
Economic Moat
Gwmvj
Capital Allocation
Dfldjnysg

Bulls Say, Bears Say

Bulls

We expect Haleon, with financial and operational independence, to bolster its portfolio through product innovation and tuck-in acquisitions and expand the strong foothold it has in the consumer self-care industry.

Bears

Personalization of health paves way for smaller niche players to carve out their shares of the market with bespoke offerings and Haleon will have a tough time fighting for these areas given the difficulty to cater to these consumers with their megabrands.

Show More

News

View All

Articles & Videos

Trading Information

Previous Close Price
$9.03
Day Range
$9.05–9.15
52-Week Range
$8.65–11.28
Bid/Ask
$8.95 / $9.10
Shares Outstanding
4.41B
Market Cap
$40.31B
Volume/Avg
8M / 9M

Key Statistics

Price/Earnings (Normalized)
18.20
Price/Sales
2.80
Dividend Yield (Trailing)
2.12%
Dividend Yield (Forward)
2.12%
Total Yield
4.27%

Company Profile

Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon’s brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Large Core
Total Number of Employees
24,524
Website
https://www.haleon.com

Competitors

Valuation

View More
Metric
HLN
RKT
KVUE
Price/Earnings (Normalized)
 18.2013.1815.57
Price/Book Value
 1.823.783.27
Price/Sales
 2.802.092.27
Price/Cash Flow
 15.3111.2914.90
Price/Earnings
HLN
RKT
KVUE

Financial Strength

Metric
HLN
RKT
KVUE
Quick Ratio
 0.690.590.68
Current Ratio
 0.920.850.98
Interest Coverage
 7.049.986.04
Quick Ratio
HLN
RKT
KVUE

Profitability

Metric
HLN
RKT
KVUE
Return on Assets (Normalized)
 5.15%9.61%7.21%
Return on Equity (Normalized)
 10.49%34.73%18.37%
Return on Invested Capital (Normalized)
 7.61%17.29%11.44%
Return on Assets
HLN
RKT
KVUE

Drug Manufacturers - Specialty & Generic Industry Comparables

Screen With Investor
1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Merck KGaA ADR
MKKGY
ZjnpctkppBymrbvf$67B
 Teva Pharmaceutical Industries Ltd ADR
TEVA
FmqbyyygcVcppxzv$40B
 Zoetis Inc Class A
ZTS
YkrrbxdhklBjyp$33B
 Viatris Inc
VTRS
PlhzzywPtwy$19B
 Elanco Animal Health Inc
ELAN
GwnSltw$12B
 Dr Reddy's Laboratories Ltd ADR
RDY
XzxmvsznRkbn$11B
 Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
BcnsxkfvvSvkss$6B
 Prestige Consumer Healthcare Inc
PBH
LndkktnrTbjcxpr$2B
 Perrigo Co PLC
PRGO
MxmthtprFcn$2B

Sponsor Center